CDW CDW Corp Insider Trading

CDW Director David W Nelms purchases 18,000 shares for $2.0M, raising stake 54.5% to 51,025 shares

Director David W Nelms purchased 18,000 shares at $111.43 on 2026-05-27 for a total value of $2,005,740.00, increasing his holdings from 33,025 shares to 51,025 shares, a net change of +54.5%. This represents a material increase in personal stake in CDW at a price -32.8% from the 52-week high of $186.70. The company trades at a P/E of 14.88 with $5.7B in quarterly revenue and +6.8% annual revenue growth, suggesting a valuation below recent peaks. The 30-day price decline of -7.5% preceded this transaction, while the stock has recovered +2.3% over 90 days, indicating the purchase occurred during a period of recent price pressure.

Christine A Leahy purchased 4,830 CDW shares at $103.40 for $499,397.85; stock has fallen 22.1% in 30 days

Christine A Leahy purchased 4,830 shares of CDW at $103.40, expanding her holdings by 2.6% to 193,356 shares total. The purchase occurs against a backdrop of significant recent price weakness: CDW has declined 22.1% over the past 30 days and 16.0% over 90 days, trading 45.7% below its 52-week high of $192.30. Her cross-ticker track record shows mixed timing outcomes (1 prior buy with +4.4% average 30-day return, but -9.8% average 90-day return with a 0.00% win rate on buys), while her same-ticker history at CDW is more promising, with 4 of 5 prior trades well-timed at the 90-day mark and her prior buy on 2024-08-01 showing +4.4% 30-day performance. Fundamentals remain stable with CDW reporting $5.7B in quarterly revenue, $235.4M net income, and a P/E of 12.38. This purchase occurs during material recent underperformance, making it notable for its timing relative to price momentum, though the modest share increase relative to her existing holdings suggests measured rather than aggressive accumulation.

CDW insider Chawla Sona sold 7,400 shares at $146.17; prior 3 CDW sales 100% well-timed at 90-day horizon

Chawla Sona sold 7.4K shares of CDW at $146.17 on 2025-12-08, reducing her holdings by 20.8% to 28,110 shares and generating $1.1M in proceeds. Notably, her prior 3 trades at CDW were all well-timed at the 90-day mark: two sales on 2024-07-16 each showed negative 90-day returns (-7.0% and -7.3%), and a 2024-06-18 sale showed -3.8% at 90 days. Her cross-ticker track record across 3 prior sells shows a 100.00% well-timed rate with an average 90d return of -6.0%, indicating a consistent pattern of selling before subsequent declines. At current price of $149.54, the stock is -27.4% from its 52-week high of $206.13, though it has risen 4.4% over the past 30 days. This sale follows an established pattern rather than a departure from it, warranting observation of the 90-day outcome to validate whether the timing pattern continues.

CDW CFO KULEVICH FREDERICK J. sells 28,159 shares for $5,375,580.66 in two transactions, reducing holdings by 43.8%

KULEVICH executed two separate sales on 2025-05-13, selling 16,171 shares at $190.62 and 11,988 shares at $191.28, for a blended average of $190.90 and total proceeds of $5,375,580.66. This sale reduces his post-transaction holdings to 36,077 shares, down from 64,236 shares pre-transaction, representing a 43.8% reduction in his equity stake. The stock currently trades at $188.43, only 1.3% below the transaction prices, and is down 21.4% from its 52-week high of $239.84. CDW's fundamentals show revenue decline of 1.8% year-over-year, a P/E of 22.84, and the company is a $24.8B market cap entity. The magnitude and speed of this large single-day reduction in executive holdings warrants observation of the company's forward guidance and operational trends.

CDW exec LEAHY CHRISTINE A sold 40,917 shares in 4 transactions for $7,423,292.63, reducing holdings by 22.0%

LEAHY CHRISTINE A executed 4 separate sales totaling 40,917 shares for $7,423,292.63 on May 8, 2025, at prices ranging from $179.99 to $182.85 (blended average $181.42), reducing her position by 22.0% to 144,930 shares post-transaction. The sales occurred as CDW stock trades at $178.94, approximately 25.4% below its 52-week high of $239.84, having risen 12.2% over the prior 30 days despite a 6.8% decline over 90 days. Her same-ticker history at CDW shows a prior buy on 2024-08-01 with poor 90-day timing (stock declined afterward), suggesting limited predictive accuracy with this company's stock movements. The transaction scale and timing relative to recent price strength warrant examination of whether the sales reflect balance-sheet actions or other non-conviction-driven factors.

CDW insider Albert Joseph Miralles Jr. bought 1,050 shares at $216.62; stock now at $206.67, down -19.8% from 52-week high.

MIRALLES ALBERT JOSEPH JR bought 1,050 shares of CDW at $216.62 on 2024-08-01, bringing total holdings to 16,875 shares (a 6.6% increase). The purchase occurred when CDW was trading near its 52-week range, though the stock has since declined to $206.67, now -19.8% from the 52-week high of $257.87. CDW reported $5.4B in revenue for the latest quarter with annual revenue growth of -10.0%, and trades at a P/E of 24.90 against a market cap of $27.6B. The open-market purchase at $216.62 against current trading at $206.67 presents a modest underwater position for this insider transaction, though the purchase size remains limited relative to CDW's overall market capitalization and liquidity.

CDW insider LEAHY CHRISTINE A bought 1.2K shares at $216.15 on 2024-08-01 (now -19.8% from 52-week high)

LEAHY CHRISTINE A purchased 1,200 shares of CDW at $216.15 on 2024-08-01, expanding her holdings to 102.2K shares. The transaction occurred during a period of price weakness: the stock is currently -4.4% over the past 30 days and -6.4% over 90 days, and trades 19.8% below its 52-week high of $257.87. Her prior three sales at CDW (all on 2023-11-15) showed no well-timed instances at the 90-day mark, with post-sale returns averaging +8.5% to +9.0%, indicating she sold ahead of rallies rather than declines. The company's fundamentals show revenue contraction (annual growth of -10.0%), though with a respectable P/E of 24.90 and market cap of $27.6B. This buy follows a pattern of prior selling at higher prices but provides no direct visibility into forward conviction given the absence of timing signal from her cross-ticker history (3 prior sells, 0% well-timed rate).

Chawla Sona sold 18,437 shares for $4,433,120.43, reducing holdings 45.1%, blended average $240.45

Sona Chawla executed 2 separate sales on 2024-07-16, disposing of 18,437 shares at a blended average price of $240.45, representing a 45.1% reduction in her CDW holdings. The current stock price of $233.70 is 9.4% below the 52-week high of $257.87, placing the transaction in the upper half of the annual range. Her cross-ticker track record shows 1 prior sell with an average 30-day return of +1.5%, and her most recent same-ticker sale on 2024-06-18 showed a 30-day return of +1.5%, though the 90-day outcome for that prior CDW sale is not yet measurable. CDW's fundamentals show annual revenue growth of -10.0% year-over-year and a P/E of 28.82; the quarterly revenue stands at $4,872,700,000.00 ($4.9B) with net income of $216,100,000.00 ($216.1M).

CDW Corp insider Chawla Sona sold 25,914 shares at $230.17 on 2024-06-18 for $5,964,625.38, reducing holdings 53.6%

Chawla Sona executed a substantial sale of 25,914 shares (25.9K shares), reducing her stake from 48,341 shares (48.3K shares) to 22,427 shares (22.4K shares)—a -53.6% reduction in holdings. The transaction occurred at $230.17, with the stock currently priced at $231.93, indicating the sale was timed slightly below recent levels. CDW faces headwinds including a -10.0% annual revenue decline and a 90-day price decline of -9.3%, though the company maintains a substantial $31.2B market cap and $216.1M net income on $4.9B quarterly revenue. The magnitude of the reduction—divesting more than half her position—combined with the company's recent revenue contraction warrants investor attention to whether other insiders are similarly adjusting their exposure.